Literature DB >> 2878646

Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.

A J MacGilchrist, J A Hunter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2878646      PMCID： PMC1002032          DOI： 10.1136/ard.45.11.967

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis.

Authors:  T W Lennard; J R Farndon
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-09

2.  Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.

Authors:  M Farr; D P Symmons; P A Bacon
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103
  2 in total
  3 in total

1.  Sulphasalazine and hepatic transaminases.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

Review 2.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

3.  Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events.

Authors:  Paresh Jobanputra; Roshan Amarasena; Fiona Maggs; Dawn Homer; Simon Bowman; Elizabeth Rankin; Andrew Filer; Karim Raza; Ronald Jubb
Journal:  BMC Musculoskelet Disord       Date:  2008-04-11       Impact factor: 2.362
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.